Although pharmacological treatment of diabetes and previous hypoglycemic episodes have been reported to increase the risk of dementia [1, 17], the incidence of hypoglycemic episodes and the frequency of use of oral antihyperglycemic agents and/or insulin (insulin doses, frequency of injection) did not show any difference between the AD and cognitively normal groups. The gene discussed is INS; the disease is Alzheimer disease.